Aminodifluorosulfinium Salts: Selective Fluorination Reagents with Enhanced Thermal Stability and Ease of Handling, A L’Heureux, F Beaulieu, C Bennett, DR Bill, S Clayton, F LaFlamme, ... The Journal of Organic Chemistry 75 (10), 3401-3411, 2010 | 367 | 2010 |
Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms M Mirmehrabi, S Rohani, KSK Murthy, B Radatus International journal of pharmaceutics 282 (1-2), 73-85, 2004 | 86 | 2004 |
Characterization of tautomeric forms of ranitidine hydrochloride: thermal analysis, solid-state NMR, X-ray M Mirmehrabi, S Rohani, KSK Murthy, B Radatus Journal of crystal growth 260 (3-4), 517-526, 2004 | 83 | 2004 |
An approach to solvent screening for crystallization of polymorphic pharmaceuticals and fine chemicals M Mirmehrabi, S Rohani Journal of pharmaceutical sciences 94 (7), 1560-1576, 2005 | 77 | 2005 |
Thermodynamic modeling of activity coefficient and prediction of solubility: Part 2. Semipredictive or semiempirical models M Mirmehrabi, S Rohani, L Perry Journal of pharmaceutical sciences 95 (4), 798-809, 2006 | 60 | 2006 |
Measurement and prediction of the solubility of stearic acid polymorphs by the UNIQUAC equation M Mirmehrabi, S Rohani The Canadian Journal of Chemical Engineering 82 (2), 335-342, 2004 | 44 | 2004 |
Polymorphic behavior and crystal habit of an anti-viral/HIV drug: Stavudine M Mirmehrabi, S Rohani, KSK Murthy, B Radatus Crystal growth & design 6 (1), 141-149, 2006 | 41 | 2006 |
Supercritical carbon dioxide for pharmaceutical co-crystal production L MacEachern, A Kermanshahi-pour, M Mirmehrabi Crystal Growth & Design 20 (9), 6226-6244, 2020 | 30 | 2020 |
Polymorphic generation through solvent selection: ranitidine hydrochloride M Trifkovic, S Rohani, M Mirmehrabi Organic process research & development 11 (1), 138-143, 2007 | 24 | 2007 |
Improving the filterability and solid density of ranitidine hydrochloride form 1 M Mirmehrabi, S Rohani, KSK Murthy, B Radatus Journal of pharmaceutical sciences 93 (7), 1692-1700, 2004 | 21 | 2004 |
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2, 4, 5-trimethyl-3, 6-dioxocyclohexa-1, 4-dienyl) butanamide P Mollard, CR Cornell, KE Wesson, P Giannousis, S Suchit, M Mirmehrabi US Patent 10,251,847, 2019 | 19 | 2019 |
Virtual multicomponent crystal screening: Hydrogen bonding revisited S Ahmadi, PK Mondal, Y Wu, W Gong, M Mirmehrabi, S Rohani Crystal Growth & Design 21 (10), 5862-5872, 2021 | 16 | 2021 |
Methods for chiral resolution of trolox P Mollard, P Giannousis, M Mirmehrabi, H Alite, A Singh US Patent App. 15/536,514, 2018 | 16 | 2018 |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi US Patent 8,022,216, 2011 | 15 | 2011 |
Stavudine M Mirmehrabi, S Rohani, MC Jennings Acta Crystallographica Section C: Crystal Structure Communications 61 (12 …, 2005 | 15 | 2005 |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-buteramide and crystalline forms thereof Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi US Patent 8,394,959, 2013 | 13 | 2013 |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi US Patent 8,173,814, 2012 | 12 | 2012 |
Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry S Deshmukh, M Mirmehrabi US Patent App. 11/634,694, 2007 | 12 | 2007 |
Maleate salts of (E)-N-{4-[3-Chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi US Patent 9,139,558, 2015 | 11 | 2015 |
Transformation under pressure: Discovery of a novel crystalline form of anthelmintic drug Praziquantel using high-pressure supercritical carbon dioxide L MacEachern, A Kermanshahi-Pour, M Mirmehrabi International Journal of Pharmaceutics 619, 121723, 2022 | 10 | 2022 |